This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Review Nat Rev Genet 2002; 3 (6): 415–28.JonesPABaylinSB.The fundamental role of epigenetic events in cancer.2002;3(6):415–28.Search in Google Scholar
Koch A, Joosten SC, Feng Z, de Ruijter TC, Draht MX, et al. Analysis of DNA methylation in cancer: location revisited. Nat Rev Clin Oncol 2018; 15 (7): 459–466.KochAJoostenSCFengZde RuijterTCDrahtMX.Analysis of DNA methylation in cancer: location revisited.2018;15(7):459–466.Search in Google Scholar
Davalos V, Esteller M. Cancer epigenetics in clinical practice. CA Cancer J Clin 2023; 73 (4): 376–424.DavalosVEstellerM.Cancer epigenetics in clinical practice.2023;73(4):376–424.Search in Google Scholar
Taryma-Lesniak O, Sokolowska KE, Wojdacz TK. Current status of development of methylation biomarkers for in vitro diagnostic IVD applications. Clin Epigenetics 2020; 12 (1): 100.Taryma-LesniakOSokolowskaKEWojdaczTK.Current status of development of methylation biomarkers for in vitro diagnostic IVD applications.2020;12(1):100.Search in Google Scholar
Ilse P, Biesterfeld S, Pomjanski N, Wrobel C, Schramm M. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis. Cancer Genomics Proteomics 2014; 11 (5): 251–258.IlsePBiesterfeldSPomjanskiNWrobelCSchrammM.Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.2014;11(5):251–258.Search in Google Scholar
Weiss G, Schlegel A, Kottwitz D, Konig T, Tetzner R. Validation of the SHOX2/PTGER4 DNA methylation marker panel for plasma-based discrimination between patients with malignant and nonmalignant lung disease. J Thorac Oncol 2017; 12 (1): 77–84.WeissGSchlegelAKottwitzDKonigTTetznerR.Validation of the SHOX2/PTGER4 DNA methylation marker panel for plasma-based discrimination between patients with malignant and nonmalignant lung disease.2017;12(1):77–84.Search in Google Scholar
Liang W, Chen Z, Li C, Liu J, Tao J, et al. Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test. J Clin Invest 2021; 131 (10): e145973.LiangWChenZLiCLiuJTaoJ.Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test.2021;131(10): e145973.Search in Google Scholar
Church TR, Wandell M, Lofton Day C, Mongin SJ, Burger M, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 2014; 63 (2): 317–325.ChurchTRWandellMLofton DayCMonginSJBurgerM.Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.2014;63(2):317–325.Search in Google Scholar
Potter NT, Hurban P, White MN, Whitlock KD, Lofton Day CE, et al. Validation of a real time PCR based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem 2014; 60 (9): 1183–1191.PotterNTHurbanPWhiteMNWhitlockKDLofton DayCE.Validation of a real time PCR based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.2014;60(9):1183–1191.Search in Google Scholar
Lewin J, Kottwitz D, Aoyama J, deVos T, Garces J, et al. Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study. BMC Gastroenterol 2021; 21 (1): 136.LewinJKottwitzDAoyamaJdeVosTGarcesJ.Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study.2021;21(1):136.Search in Google Scholar
Oh TJ, Oh HI, Seo YY, Jeong D, Kim C, et al. Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer. Clin Epigenetics 2017; 9 (1): 126.OhTJOhHISeoYYJeongDKimC.Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer.2017;9(1):126.Search in Google Scholar
Johannessen LE, Brandal P, Myklebust T, Heim S, Micci F, Panagopoulos I. MGMT Gene Promoter methylation status—Assessment of two pyrosequencing kits and three methylation-specific PCR methods for their predictive capacity in glioblastomas. Cancer Genomics Proteomics 2018; 15 (6): 437–48.JohannessenLEBrandalPMyklebustTHeimSMicciFPanagopoulosI.MGMT Gene Promoter methylation status—Assessment of two pyrosequencing kits and three methylation-specific PCR methods for their predictive capacity in glioblastomas.2018;15(6):437–48.Search in Google Scholar
Bonde J, Floore A, Ejegod D, Vink FJ, Hesselink A, et al. Methylation markers FAM19A4 and miR1242 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study. Int J Cancer 2021; 148 (2): 396–405.BondeJFlooreAEjegodDVinkFJHesselinkA.Methylation markers FAM19A4 and miR1242 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study.2021;148(2):396–405.Search in Google Scholar
Schmitz M, Eichelkraut K, Schmidt D, Zeiser I, Hilal Z, et al. Performance of a DNA methylation marker panel using liquidbased cervical scrapes to detect cervical cancer and its precancerous stages. BMC Cancer 2018; 18 (1): 1–8.SchmitzMEichelkrautKSchmidtDZeiserIHilalZ.Performance of a DNA methylation marker panel using liquidbased cervical scrapes to detect cervical cancer and its precancerous stages.2018;18(1):1–8.Search in Google Scholar
Liou YL, Zhang TL, Yan T, Yeh CT, Kang YN, et al. Combined clinical and genetic testing algorithm for cervical cancer diagnosis. Clin Epigenetics 2016; 8: 66.LiouYLZhangTLYanTYehCTKangYN.Combined clinical and genetic testing algorithm for cervical cancer diagnosis.2016;8:66.Search in Google Scholar
Schricker G, Napieralski R, Noske A, Piednoir E, Manner O, et al. Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA methylation in breast cancer. Sci Rep 2018; 8 (1): 16861.SchrickerGNapieralskiRNoskeAPiednoirEMannerO.Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA methylation in breast cancer.2018;8(1):16861.Search in Google Scholar
Ruan W, Chen X, Huang M, Wang H, Chen J, et al. A urine based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer. Clin Epigenetics 2021; 13 (1): 91.RuanWChenXHuangMWangHChenJ.A urine based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer.2021;13(1):91.Search in Google Scholar
Witjes JA, Morote J, Cornel EB, Gakis G, van Valenberg FJP, et al. Performance of the bladder EpiCheck methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial. Eur Urol Oncol 2018; 1 (4): 307–13.WitjesJAMoroteJCornelEBGakisGvan ValenbergFJP.Performance of the bladder EpiCheck methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial.2018;1(4):307–13.Search in Google Scholar
Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, et al. Identifying DNA methylation biomarkers for non endoscopic detection of Barrett’s esophagus. Sci Transl Med 2018; 10 (424): aao5848.MoinovaHRLaFramboiseTLutterbaughJDChandarAKDumotJ.Identifying DNA methylation biomarkers for non endoscopic detection of Barrett’s esophagus.2018;10(424): aao5848.Search in Google Scholar
Moran S, Martinez-Cardus A, Sayols S, Musulen E, Balana C, et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol 2016; 17 (10): 1386–95.MoranSMartinez-CardusASayolsSMusulenEBalanaC.Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.2016;17(10):1386–95.Search in Google Scholar
Liang N, Li B, Jia Z, Wang C, Wu P, et al. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning. Nat Biomed Eng 2021; 5 (6): 586–599.LiangNLiBJiaZWangCWuP.Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning.2021;5(6):586–599.Search in Google Scholar